**6. Conclusions**

Multiple sclerosis is a complex autoimmune disease. Due to the many cell types involved in pathogenesis of the disease, therapeutics and treatments are often broad ranged and relatively inefficient. Further studies are necessary to uncover the genetic and environmental triggers leading to aberrant cellular toxicity and its role in MS

pathogenesis. Discovering these and the related pathways will potentially lead to more targeted therapeutics and the elimination of not only MS but other autoimmune and neurological diseases in the future.
